Octave Presents Data from 13 Abstracts at ECTRIMS Forum 2022 Following Commercial Launch of Precision Care Solution for Multiple Sclerosis

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave, a leading digital health sciences company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today announced the presentation of data from 13 abstracts presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Conference 2022. The posters...

Click to view original post